pentobarbital will lessen the extent or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers may possibly lower partiaprevir and ritonavir levels, and therefore lessened efficacy of Viekira